BREAKING NEWS: New drug approved by the FDA for Duchenne muscular dystrophy. Learn more about this new treatment option.

Innovations in Care

We provide access to support and programs that empower the lives of people living with neuromuscular diseases.

MDA Engage - California

Saturday, November 11, 2023MDA Engage Logo
9:00am - 4:30pm
Paul and Mildred Berg Conference Center, Li Ka Shing Building
291 Campus Drive, Stanford, CA 94305

 

 

Watch Recordings

MDA is pleased to have Dr. John W. Day, Professor, Neurology & Neurological Sciences Director, Stanford Neuromuscular Disorders Program at Stanford University, presenting the Keynote Address.

Headshot of John W. Day, MD, PhD
John W. Day, MD, PhD
Professor, Neurology & Neurological Sciences Director
Stanford Neuromuscular Disorders Program
Stanford University

Individual Session Recordings

 

Thank you to our symposium supporters

Empowerment Sponsors

  • Argenx
  • Avidity Biosciences
  • Biomarin
  • Edgewise Therapeutics

Champion Sponsors

  • Alexion
  • Janssen Pharmaceutica
  • Sarepta
  • UCB Community Health Fund